VERV logo

Verve Therapeutics (VERV)

Profile

Full Name

Verve Therapeutics, Inc.

Ticker Symbol

VERV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 17, 2021

Indexes

Not included

Website

http://www.vervetx.com

Employees

274

Key Details

Price

$4.97(+20.63%)

Market cap

$441.32M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$32.33M(+174.98% YoY)

Annual EPS

-$2.35(+24.68% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.97
VERV price is $4.97

30-Day Relative Volume

7.16
VERV 30-day relative volume is 7.16

Price Performance

Price Most recent change

+20.63%
VERV price was up +20.63% on Apr 15, 2025

Price YTD change

-11.88%
VERV price is down -11.88% since January 1st

Price 1-year change

-32.01%
VERV price is down -32.01% year-on-year

Price 3-year change

-75.55%
VERV price is down -75.55% over the past 3 years

Price Range

Price All-time high

$78.00
VERV price is currently -93.63% below its historical high of $78.00

Price 3-year low

$2.87
VERV price is currently +73.47% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$441.32M
VERV market capitalization is $441.32 million

Market cap 3-year change

-55.39%
VERV market capitalization is down -55.39% over the past 3 years

Market cap All-time high

$3.55B
VERV market capitalization is currently -87.57% below its historical high of $3.55 billion

Market cap sector rank

67.85%
VERV market capitalization is higher than 67.85% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+5.81%
VERV shares outstanding is up +5.81% year-on-year

Shares Outstanding 3-Year Change

+82.48%
VERV shares outstanding is up +82.48% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.65
VERV beta is 1.65

200-day SMA

$5.90
VERV price is currently -15.77% below its 200-day simple moving average

50-day SMA

$6.04
VERV price is currently -17.69% below its 50-day simple moving average

RSI

52.47
VERV 14-day relative strength index is 52.47

Volume

7.16
VERV 30-day relative volume is 7.16

ATR

$0.61
VERV average true range is $0.61

10-day Historical Volatility

216.84%
VERV 10-day historical volatility is 216.84%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$32.33M
VERV annual revenue is $32.33 million

Revenue Analysts estimate

$24.15M
VERV annual revenue is currently +33.87% higher than the consensus analysts' forecast

Revenue 1-year change

+174.98%
VERV annual revenue is up +174.98% year-on-year

Revenue Sector rank

40.78%
VERV annual revenue is higher than 40.78% of companies in Healthcare sector

EPS

EPS

-$2.35
VERV annual earnings per share is -$2.35

EPS Analysts estimate

-$2.64
VERV annual earnings per share is currently -11.06% lower than the consensus analysts' forecast

EPS 1-year change

+24.68%
VERV annual earnings per share is up +24.68% year-on-year

EPS Sector rank

35.29%
VERV annual earnings per share is higher than 35.29% of companies in Healthcare sector

Profit

Gross profit

-
VERV annual gross profit value is unknown

Gross margin

-
VERV annual gross profit margin value is unknown

Operating profit

-$228.66M
VERV annual operating income is -$228.66 million

Operating margin

-707.23%
VERV annual operating profit margin is -707.23%

Net income

-$198.71M
VERV annual net profit is -$198.71 million

Net margin

-614.59%
VERV annual net profit margin is -614.59%

Expenses

Total expenses

$260.99M
VERV annual total expenses is $260.99 million

Operating expenses

$260.99M
VERV annual total operating expenses is $260.99 million

Cost of goods sold

-
VERV annual cost of goods sold value is unknown

Selling, general & administrative expenses

$56.65M
VERV annual SGA is $56.65 million

Depreciation and amortization

$6.75M
VERV annual depreciation & amortization is $6.75 million

Interest expense

-
VERV annual interest expense value is unknown

Income tax

$349.00K
VERV annual income tax is $349.00 thousand

EBIT & EBITDA

EBIT

-$228.66M
VERV annual earnings before interest & taxes is -$228.66 million

EBITDA

-$221.91M
VERV annual EBITDA is -$221.91 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$647.39M
VERV annual total assets is $647.39 million

Non current assets

$104.64M
VERV annual long term assets is $104.64 million

Current assets

$542.75M
VERV annual total current assets is $542.75 million

Cash and cash equivalents

$172.56M
VERV annual cash & cash equivalents is $172.56 million

Accounts receivable

-
VERV annual accounts receivable value is unknown

Inventory

-
VERV annual inventory value is unknown

Liabilities

Total liabilities

$153.99M
VERV annual total liabilities is $153.99 million

Long term liabilities

$111.08M
VERV annual total long term liabilities is $111.08 million

Current liabilities

$42.91M
VERV annual total current liabilities is $42.91 million

Accounts payable

$4.52M
VERV annual accounts payable is $4.52 million

Debt

Total debt

$69.98M
VERV annual total debt is $69.98 million

Total debt 1-year change

-6.57%
VERV annual total debt is down -6.57% year-on-year

Long term debt

$59.54M
VERV annual long term debt is $59.54 million

Short term debt

$10.44M
VERV annual short term debt is $10.44 million

Equity & Capital

Shareholders equity

$493.40M
VERV annual stockholders equity is $493.40 million

Book value

$493.40M
VERV annual book value is $493.40 million

Retained earnings

-$743.01M
VERV annual retained earnings is -$743.01 million

Working capital

$499.84M
VERV annual working capital is $499.84 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$157.69M
VERV annual cash flow from operations is -$157.69 million

Cash from operations 1-year change

-5.45%
VERV annual cash flow from operations is down -5.45% year-on-year

Cash from investing

$74.88M
VERV annual cash flow from investing activities is $74.88 million

Cash from investing 1-year change

+170.41%
VERV annual cash flow from investing activities is up +170.41% year-on-year

Cash from financing

$49.20M
VERV annual cash flow from financing activities is $49.20 million

Cash from financing 1-year change

-76.86%
VERV annual cash flow from financing activities is down -76.86% year-on-year

CAPEX

CAPEX

$3.74M
VERV annual capital expenditures is $3.74 million

CAPEX 1-year change

-59.75%
VERV annual capital expenditures is down -59.75% year-on-year

Free Cash Flow

Free cash flow

-$161.43M
VERV annual free cash flow is -$161.43 million

Free cash flow 1-year change

-1.63%
VERV annual free cash flow is down -1.63% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
VERV annual gross profit margin value is unknown

Operating margin

-707.23%
VERV annual operating profit margin is -707.23%

Net margin

-614.59%
VERV annual net profit margin is -614.59%

ROA & ROE

ROA

-28.39%
VERV annual return on assets is -28.39%

ROE

-36.36%
VERV annual return on equity is -36.36%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VERV price to earnings ratio value is unknown

PE ratio Sector rank

-
VERV price to earnings ratio is unknown

PB Ratio

PB ratio

0.89
VERV price to book ratio is 0.89

PB ratio Sector rank

41.81%
VERV price to book ratio is higher than 41.81% of companies in Healthcare sector

PS Ratio

PS ratio

13.65
VERV price to sales ratio is 13.65

PS ratio Sector rank

83.46%
VERV price to sales ratio is higher than 83.46% of companies in Healthcare sector

Enterprise value

Enterprise value

$338.74M
VERV enterprise value is $338.74 million

Enterprise value Sector rank

64.43%
VERV enterprise value is higher than 64.43% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.53
VERV EV/EBITDA is -1.53

EV/EBITDA Sector rank

36.64%
VERV EV/EBITDA is higher than 36.64% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

12.65
VERV annual current ratio is 12.65

Quick ratio

-
VERV annual quick ratio value is unknown

Leverage

Debt to equity

0.00
VERV annual debt to equity ratio is 0.00

Interest coverage ratio

-
VERV annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
VERV piotroski f-score value is unknown

Altman Z-Score

-0.08
VERV altman z-score is -0.08

Analyst ratings

Recent major analysts updates

Apr 14, 25 HC Wainwright & Co.
Buy
Mar 25, 25 HC Wainwright & Co.
Buy
Mar 25, 25 Guggenheim
Buy
Mar 4, 25 RBC Capital
Outperform
Feb 28, 25 HC Wainwright & Co.
Buy
Nov 6, 24 RBC Capital
Outperform
Nov 6, 24 HC Wainwright & Co.
Buy
Nov 6, 24 Canaccord Genuity
Buy
Aug 12, 24 HC Wainwright & Co.
Buy
Aug 12, 24 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

CeriBell (CBLL)
Fortrea Holdings (FTRE)
LAB logo
Standard BioTools (LAB)
CAPR logo
Capricor Therapeutics (CAPR)
MDRX logo
Veradigm (MDRX)
SIGA logo
SIGA Technologies (SIGA)
MGTX logo
MeiraGTx Holdings (MGTX)
TBPH logo
Theravance Biopharma (TBPH)
CGEM logo
Cullinan Oncology (CGEM)
  • What is the ticker symbol for Verve Therapeutics?
  • Does Verve Therapeutics pay dividends?
  • What sector is Verve Therapeutics in?
  • What industry is Verve Therapeutics in?
  • What country is Verve Therapeutics based in?
  • When did Verve Therapeutics go public?
  • Is Verve Therapeutics in the S&P 500?
  • Is Verve Therapeutics in the NASDAQ 100?
  • Is Verve Therapeutics in the Dow Jones?
  • When was Verve Therapeutics's last earnings report?
  • When does Verve Therapeutics report earnings?
  • Should I buy Verve Therapeutics stock now?

What is the ticker symbol for Verve Therapeutics?

The ticker symbol for Verve Therapeutics is NASDAQ:VERV

Does Verve Therapeutics pay dividends?

No, Verve Therapeutics does not pay dividends

What sector is Verve Therapeutics in?

Verve Therapeutics is in the Healthcare sector

What industry is Verve Therapeutics in?

Verve Therapeutics is in the Biotechnology industry

What country is Verve Therapeutics based in?

Verve Therapeutics is headquartered in United States

When did Verve Therapeutics go public?

Verve Therapeutics's initial public offering (IPO) was on June 17, 2021

Is Verve Therapeutics in the S&P 500?

No, Verve Therapeutics is not included in the S&P 500 index

Is Verve Therapeutics in the NASDAQ 100?

No, Verve Therapeutics is not included in the NASDAQ 100 index

Is Verve Therapeutics in the Dow Jones?

No, Verve Therapeutics is not included in the Dow Jones index

When was Verve Therapeutics's last earnings report?

Verve Therapeutics's most recent earnings report was on Feb 27, 2025

When does Verve Therapeutics report earnings?

The next expected earnings date for Verve Therapeutics is May 15, 2025

Should I buy Verve Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page